These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9616192)

  • 1. Analysis of metabolite formation pharmacokinetics after intravenous and oral administration of the parent drug using inverse Laplace transformation.
    Weiss M
    Drug Metab Dispos; 1998 Jun; 26(6):562-5. PubMed ID: 9616192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The time to reach steady state after the administration of intravenous bolus, constant infusion, and oral immediate-release and sustained-release preparations.
    Chow MS; Sun H
    Pharmacotherapy; 1990; 10(6):400-5. PubMed ID: 2287561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of metabolite pharmacokinetics for orally administered prodrugs.
    Kochak GM; Rakhit A
    Drug Metab Dispos; 1987; 15(4):456-9. PubMed ID: 2888616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and oral bioavailability of pentoxyfylline in broiler chickens.
    De Boever S; Baert K; De Backer P; Croubels S
    J Vet Pharmacol Ther; 2005 Dec; 28(6):575-80. PubMed ID: 16343291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic modelling of pentoxifylline and lisofylline after oral and intravenous administration in mice.
    Wyska E; Szymura-Oleksiak J; Pekala E; Obruśnik A
    J Pharm Pharmacol; 2007 Apr; 59(4):495-501. PubMed ID: 17430632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective pharmacokinetic analysis of tramadol and its main phase I metabolites in healthy subjects after intravenous and oral administration of racemic tramadol.
    García Quetglas E; Azanza JR; Cardenas E; Sádaba B; Campanero MA
    Biopharm Drug Dispos; 2007 Jan; 28(1):19-33. PubMed ID: 17061296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of (-)-epicatechin in rabbits.
    Chen YA; Hsu KY
    Arch Pharm Res; 2009 Jan; 32(1):149-54. PubMed ID: 19183888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New models for pharmacokinetic data based on a generalized Weibull distribution.
    Heikkilä HJ
    J Biopharm Stat; 1999 Mar; 9(1):89-107. PubMed ID: 10091912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
    Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
    Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of pentoxifylline and its 5-hydroxyhexyl metabolite after oral and intravenous administration of pentoxifylline to healthy adult horses.
    Liska DA; Akucewich LH; Marsella R; Maxwell LK; Barbara JE; Cole CA
    Am J Vet Res; 2006 Sep; 67(9):1621-7. PubMed ID: 16948611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and kinetic-dynamic modeling of an 8-aminoquinoline candidate anticyanide and antimalarial drug (WR242511).
    Marino MT; Peggins JO; Brown LD; Urquhart MR; Brewer TG
    Drug Metab Dispos; 1994; 22(3):358-66. PubMed ID: 8070311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
    Ramanathan-Girish S; Catz P; Creek MR; Wu B; Thomas D; Krogstad DJ; De D; Mirsalis JC; Green CE
    Int J Toxicol; 2004; 23(3):179-89. PubMed ID: 15204721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development and identifiability analysis of parent-metabolite pharmacokinetic model for risperidone and its main active metabolite 9-hydroxyrisperidone].
    Ding JJ; Jiao Z; Yu YQ; Shi XJ
    Yao Xue Xue Bao; 2007 Jun; 42(6):631-8. PubMed ID: 17702401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacokinetic model for analysis of drug disposition profiles undergoing enterohepatic circulation.
    Wajima T; Yano Y; Oguma T
    J Pharm Pharmacol; 2002 Jul; 54(7):929-34. PubMed ID: 12162711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fraction of absorbed drug at the time of peak plasma concentration in an open one-compartment model after simultaneous oral and intravenous administration.
    Plusquellec Y; Houin G
    Arzneimittelforschung; 1992 Mar; 42(3):350-2. PubMed ID: 1497698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of 9-nitro-20(S)-camptothecin in rats.
    Zhong DF; Li K; Xu JH; Du Y; Zhang YF
    Acta Pharmacol Sin; 2003 Mar; 24(3):256-62. PubMed ID: 12617776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic-pharmacodynamic and metabolite modeling with TopFit.
    Tanswell P; Heinzel G; Weisenberger H; Roth W
    Int J Clin Pharmacol Ther; 1995 Oct; 33(10):550-4. PubMed ID: 8574505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the pharmacokinetics and bioavailability of intravenously and orally administered amiodarone in horses.
    De Clercq D; Baert K; Croubels S; van Loon G; Maes A; Tavernier R; Deprez P; De Backer P
    Am J Vet Res; 2006 Mar; 67(3):448-54. PubMed ID: 16506906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A general model of metabolite kinetics following intravenous and oral administration of the parent drug.
    Weiss M
    Biopharm Drug Dispos; 1988; 9(2):159-76. PubMed ID: 3370305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.